CULLINAN THERAPEUTICS
16.51
07-November-24 11:26:19
15 minutes delayed
Stocks
+0.03
+0.18%
Today's range
16.35 - 17.19
ISIN
N/A
Source
NASDAQ
-
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
17 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
16 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
14 Sep 2024 04:15:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
28 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
08 Aug 2024 07:00:01 By Nasdaq GlobeNewswire
-
01 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
24 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
23 May 2024 17:04:38 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
29 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
16 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
16 Apr 2024 06:59:00 By Nasdaq GlobeNewswire
-
14 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
01 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
27 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >